Covid-19 roundup: Brazil holds Sino­vac dos­es af­ter man­u­fac­tur­ing mix up; Take­da to pro­duce No­vavax vac­cine

The use of more than 12.1 mil­lion dos­es of the Chi­nese Sino­vac vac­cine will be halt­ed in Brazil, af­ter reg­u­la­tors learned that the man­u­fac­tur­ing site was not ap­proved for emer­gency use by An­visa, the na­tion­al health agency.

An­visa an­nounced the 90-day sus­pen­sion in a state­ment Sat­ur­day. An­oth­er 17 batch­es, or 9 mil­lion dos­es, are al­so en route to Brazil, and will be held due to be­ing bot­tled at a site that was not in­spect­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER